Specific Knockdown of the D2 Long Dopamine Receptor Variant

NeuroReport - United States
doi 10.1097/wnr.0b013e32834d2216
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Analysis of the Actions of the Novel Dopamine Receptor-Directed Compounds (S)-Osu6162 and ACR16 at the D2 Dopamine Receptor

British Journal of Pharmacology
Pharmacology
2010English

Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity

Biological Psychiatry
Biological Psychiatry
2013English

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2016English

D1 and D2 Dopamine Receptor mRNA in Rat Brain.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Analogues of the Dopamine D2 Receptor Antagonist L741,626: Binding, Function, and SAR

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2007English

The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

An Astroglia-Linked Dopamine D2-Receptor Action in Prefrontal Cortex

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Increasing Dopamine D2 Receptor Expression in the Adult Nucleus Accumbens Enhances Motivation

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2013English

Genetic Variation and the D2 Dopamine Receptor: Implications for the Treatment of Neuropsychiatric Disease

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy